Literature DB >> 8156993

Cdc25A is a novel phosphatase functioning early in the cell cycle.

S Jinno1, K Suto, A Nagata, M Igarashi, Y Kanaoka, H Nojima, H Okayama.   

Abstract

The cdc25+ tyrosine phosphatase is a key mitotic inducer of the fission yeast Schizosaccharomyces pombe, controlling the timing of the initiation of mitosis. Mammals contain at least three cdc25+ homologues called cdc25A, cdc25B and cdc25C. In this study we investigate the biological function of cdc25A. Although very potent in rescuing the S.pombe cdc25 mutant, cdc25A is less structurally related to the S.pombe enzyme. Northern and Western blotting detection reveals that unlike cdc25B, cdc25C and cdc2, cdc25A is predominantly expressed in late G1. Moreover, immunodepletion of cdc25A in rat cells by microinjection of a specific antibody effectively blocks their cell cycle progression from G1 into the S phase, as determined by laser scanning single cell cytometry. These results indicate that cdc25A is not a mitotic regulator but a novel phosphatase that plays a crucial role in the start of the cell cycle. In view of its strong ability to activate cdc2 kinase and its specific expression in late G1, cdc2-related kinases functioning early in the cell cycle may be targets for this phosphatase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156993      PMCID: PMC394984          DOI: 10.1002/j.1460-2075.1994.tb06417.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2.

Authors:  K Lundgren; N Walworth; R Booher; M Dembski; M Kirschner; D Beach
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes.

Authors:  F Fang; J W Newport
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

3.  Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation.

Authors:  J Ninomiya-Tsuji; S Nomoto; H Yasuda; S I Reed; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

4.  Wee1(+)-like gene in human cells.

Authors:  M Igarashi; A Nagata; S Jinno; K Suto; H Okayama
Journal:  Nature       Date:  1991-09-05       Impact factor: 49.962

5.  cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2.

Authors:  J Gautier; M J Solomon; R N Booher; J F Bazan; M W Kirschner
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

6.  Human D-type cyclin.

Authors:  Y Xiong; T Connolly; B Futcher; D Beach
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

7.  Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein.

Authors:  U Strausfeld; J C Labbé; D Fesquet; J C Cavadore; A Picard; K Sadhu; P Russell; M Dorée
Journal:  Nature       Date:  1991-05-16       Impact factor: 49.962

8.  Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

Authors:  A Koff; F Cross; A Fisher; J Schumacher; K Leguellec; M Philippe; J M Roberts
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

9.  Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast.

Authors:  D J Lew; V Dulić; S I Reed
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

10.  A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1.

Authors:  S J Elledge; M R Spottswood
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  110 in total

1.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.

Authors:  X Chen; R Prywes
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

4.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 5.  Cdc25 as a potential target of anticancer agents.

Authors:  J W Eckstein
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

6.  Cdc25B functions as a novel coactivator for the steroid receptors.

Authors:  Z Q Ma; Z Liu; E S Ngan; S Y Tsai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase.

Authors:  M S Chen; J Hurov; L S White; T Woodford-Thomas; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 8.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

9.  Role of Plk2 (Snk) in mouse development and cell proliferation.

Authors:  Sheng Ma; Jean Charron; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 10.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.